Year |
Citation |
Score |
2020 |
Dessein R, Bauduin M, Grandjean T, Le Guern R, Figeac M, Beury D, Faure K, Faveeuw C, Guery B, Gosset P, Kipnis E. Antibiotic-related gut dysbiosis induces lung immunodepression and worsens lung infection in mice. Critical Care (London, England). 24: 611. PMID 33076936 DOI: 10.1186/s13054-020-03320-8 |
0.647 |
|
2019 |
Beury D, Fléchon L, Maurier F, Caboche S, Varré JS, Touzet H, Faure K, Dubuisson J, Hot D, Guery B, Goffard A. Use of whole-genome sequencing in the molecular investigation of care-associated HCoV-OC43 infections in a hematopoietic stem cell transplant unit. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 122: 104206. PMID 31783264 DOI: 10.1016/J.Jcv.2019.104206 |
0.581 |
|
2019 |
Bortolotti P, Kipnis E, Faure E, Faure K, Wacrenier A, Fauquembergue M, Penven M, Messaadi S, Marceau L, Dessein R, Le Guern R. Clostridium ventriculi bacteremia following acute colonic pseudo-obstruction: A case report. Anaerobe. 59: 32-34. PMID 31103530 DOI: 10.1016/J.Anaerobe.2019.05.005 |
0.314 |
|
2019 |
Guern RL, Grandjean T, Bauduin M, Figeac M, Millot G, Loquet A, Faure K, Kipnis E, Dessein R. The Impact of Timing of Antibiotics on Digestive Colonization with Carbapenemase-Producing in a Murine Model. Antimicrobial Agents and Chemotherapy. PMID 30962336 DOI: 10.1128/Aac.00360-19 |
0.34 |
|
2017 |
Prevotat A, Rouyer C, Gosset P, Kipnis E, Faure K, Guery B. Biphasic lung injury during Streptococcus pneumoniae infection in a murine model. Medecine Et Maladies Infectieuses. PMID 29191391 DOI: 10.1016/J.Medmal.2017.11.001 |
0.489 |
|
2017 |
Lopez B, Boucher A, Bahuaud M, Mortuaire G, Melliez H, Launay D, Terriou L, Wemeau-Stervinou L, Wallaert B, Faure K, Wallet F, Hachulla E, Hatron PY, Dubucquoi S, Batteux F, et al. Specific polysaccharide antibody deficiency revealed by severe bacterial infections in adulthood: a report on eleven cases. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28379361 DOI: 10.1093/Cid/Cix284 |
0.355 |
|
2017 |
Sanges S, Wallet F, Blondiaux N, Theis D, Verin I, Vachée A, Dessein R, Faure K, Viget N, Senneville E, Leroy O, Maury F, Just N, Poissy J, Mathieu D, et al. Diagnosis of primary antibody and complement immunodeficiencies in young adults after a first invasive bacterial infection. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 28192236 DOI: 10.1016/J.Cmi.2017.02.005 |
0.329 |
|
2016 |
Mambie A, Wallet F, Scherman L, Armand S, Vervelle C, Faure K, Guery B, Titécat M, Loïez C. Neither Neoplasia Nor Tuberculosis, but Francisella. Open Forum Infectious Diseases. 3: ofw080. PMID 27419157 DOI: 10.1093/Ofid/Ofw080 |
0.571 |
|
2016 |
Bortolotti P, Hennart B, Thieffry C, Jausions G, Faure E, Grandjean T, Thepaut M, Dessein R, Allorge D, Guery BP, Faure K, Kipnis E, Toussaint B, Le Gouellec A. Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship. Bmc Microbiology. 16: 137. PMID 27392067 DOI: 10.1186/S12866-016-0756-X |
0.784 |
|
2016 |
Mambie A, Vuotto F, Poitrenaud D, Weyrich P, Cannesson O, Dessein R, Faure K, Guery B, Galpérine T. Cefoxitin: An alternative to carbapenems in urinary tract infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae. Medecine Et Maladies Infectieuses. PMID 27210283 DOI: 10.1016/J.Medmal.2016.04.008 |
0.568 |
|
2016 |
Faure E, Bortolotti P, Kipnis E, Faure K, Guery B. Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways. Journal of Visualized Experiments : Jove. PMID 26863066 DOI: 10.3791/53218 |
0.641 |
|
2016 |
Deconinck L, Flateau C, Pichenot M, Morell-Dubois S, Maillard H, Hatron PY, Guery B, Faure K. Antiviral therapy of primary cytomegalovirus infection with vascular thrombosis in immunocompetent adults. MéDecine Et Maladies Infectieuses. 46: 87-92. PMID 26850899 DOI: 10.1016/J.Medmal.2015.12.013 |
0.331 |
|
2015 |
Guery B, Grandbastien B, Galpérine T, Faure K. Ebola et autres, ces virus venus d’ailleurs RéAnimation. 24: 379-385. PMID 32288742 DOI: 10.1007/S13546-014-1003-9 |
0.498 |
|
2015 |
Thépaut M, Grandjean T, Hober D, Lobert PE, Bortolotti P, Faure K, Dessein R, Kipnis E, Guery B. Protective role of murine norovirus against Pseudomonas aeruginosa acute pneumonia. Veterinary Research. 46: 91. PMID 26338794 DOI: 10.1186/S13567-015-0239-3 |
0.793 |
|
2015 |
Hajji F, Beraud G, Genay A, Raoul G, Faure K, Guery B, Ferri J. Extensive Inflammatory Gingival Tumor in a Young Nonsmoking Woman: Back to Basics. The Journal of Craniofacial Surgery. 26: e388-90. PMID 26163848 DOI: 10.1097/Scs.0000000000001865 |
0.52 |
|
2014 |
Boukerb AM, Rousset A, Galanos N, Méar JB, Thépaut M, Grandjean T, Gillon E, Cecioni S, Abderrahmen C, Faure K, Redelberger D, Kipnis E, Dessein R, Havet S, Darblade B, et al. Antiadhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection. Journal of Medicinal Chemistry. 57: 10275-89. PMID 25419855 DOI: 10.1021/Jm500038P |
0.778 |
|
2014 |
Faure E, Mear JB, Faure K, Normand S, Couturier-Maillard A, Grandjean T, Balloy V, Ryffel B, Dessein R, Chignard M, Uyttenhove C, Guery B, Gosset P, Chamaillard M, Kipnis E. Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome. American Journal of Respiratory and Critical Care Medicine. 189: 799-811. PMID 24555512 DOI: 10.1164/Rccm.201307-1358Oc |
0.775 |
|
2014 |
Mear JB, Gosset P, Kipnis E, Faure E, Dessein R, Jawhara S, Fradin C, Faure K, Poulain D, Sendid B, Guery B. Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal response. Infection and Immunity. 82: 306-15. PMID 24166952 DOI: 10.1128/Iai.01085-13 |
0.79 |
|
2013 |
Méar JB, Kipnis E, Faure E, Dessein R, Schurtz G, Faure K, Guery B. Candida albicans and Pseudomonas aeruginosa interactions: more than an opportunistic criminal association? Medecine Et Maladies Infectieuses. 43: 146-51. PMID 23622953 DOI: 10.1016/J.Medmal.2013.02.005 |
0.622 |
|
2013 |
Buyck JM, Verriere V, Benmahdi R, Higgins G, Guery B, Matran R, Harvey BJ, Faure K, Urbach V. P. aeruginosa LPS stimulates calcium signaling and chloride secretion via CFTR in human bronchial epithelial cells. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 12: 60-7. PMID 22809761 DOI: 10.1016/J.Jcf.2012.06.007 |
0.547 |
|
2012 |
Vuotto F, Faure K, Queyre V, Dessein R, Pasquet A, Lambert M, Haulon S, Beregi J, Guery B, Hatron P. Vascular nosocomial Nocardia farcinica infection after arterial stenting in an immunocompetent patient. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale. 22: e10-1. PMID 22379487 DOI: 10.1155/2011/216873 |
0.582 |
|
2012 |
Kipnis É, Dessein R, Faure K, Guery B. Les thérapeutiques anti-infectieuses non antibiotiques RéAnimation. 21: 303-316. DOI: 10.1007/S13546-012-0472-Y |
0.539 |
|
2011 |
Ader F, Jawhara S, Nseir S, Kipnis E, Faure K, Vuotto F, Chemani C, Sendid B, Poulain D, Guery B. Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model. Critical Care (London, England). 15: R150. PMID 21689424 DOI: 10.1186/Cc10276 |
0.774 |
|
2011 |
Le Berre R, Nguyen S, Nowak E, Kipnis E, Pierre M, Quenee L, Ader F, Lancel S, Courcol R, Guery BP, Faure K. Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia. Critical Care Medicine. 39: 2113-20. PMID 21572326 DOI: 10.1097/Ccm.0B013E31821E899F |
0.775 |
|
2009 |
Boutoille D, Marechal X, Pichenot M, Chemani C, Guery B, Faure K. FITC-albumin as a marker for assessment of endothelial permeability in mice: comparison with 125I-albumin. Experimental Lung Research. 35: 263-71. PMID 19415544 DOI: 10.1080/01902140802632290 |
0.75 |
|
2009 |
Chemani C, Imberty A, de Bentzmann S, Pierre M, Wimmerová M, Guery BP, Faure K. Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands. Infection and Immunity. 77: 2065-75. PMID 19237519 DOI: 10.1128/Iai.01204-08 |
0.775 |
|
2008 |
Boussekey N, Chiche A, Faure K, Devos P, Guery B, d'Escrivan T, Georges H, Leroy O. A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Medicine. 34: 1646-53. PMID 18542921 DOI: 10.1007/S00134-008-1127-3 |
0.532 |
|
2008 |
Pierre M, Le Berre R, Tiesset H, Faure K, Guery B, Desseyn JL, Galabert C, Béghin L, Beermann C, Gottrand F, Husson MO. [Kinetics of Pseudomonas aeruginosa virulence gene expression during chronic lung infection in the murine model]. MéDecine Et Maladies Infectieuses. 38: 318-23. PMID 18455339 DOI: 10.1016/J.Medmal.2008.03.001 |
0.649 |
|
2008 |
Ader F, Le Berre R, Fackeure R, Raze D, Menozzi FD, Viget N, Faure K, Kipnis E, Guery B, Jarraud S, Etienne J, Chidiac C. In vivo effect of adhesion inhibitor heparin on Legionella pneumophila pathogenesis in a murine pneumonia model. Intensive Care Medicine. 34: 1511-9. PMID 18365173 DOI: 10.1007/S00134-008-1063-2 |
0.79 |
|
2008 |
Le Berre R, Nguyen S, Nowak E, Kipnis E, Pierre M, Ader F, Courcol R, Guery BP, Faure K. Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 14: 337-43. PMID 18190582 DOI: 10.1111/J.1469-0691.2007.01925.X |
0.362 |
|
2007 |
Ader F, Faure K, Guery B, Nseir S. [Pseudomonas aeruginosa and Candida albicans interaction in the respiratory tract: from pathophysiology to a therapeutic perspective]. Pathologie-Biologie. 56: 164-9. PMID 17905537 DOI: 10.1016/J.PATBIO.2007.06.002 |
0.313 |
|
2007 |
Pukenyte E, Nguyen S, Le Berre R, Faure K, Viget N, Melliez H, Mira JP, Guery B, Yazdanpanah Y. [Pneumonia with septicemia caused by Pasteurella multocida in an immunocompetent patient]. Medecine Et Maladies Infectieuses. 37: 354-6. PMID 17303362 DOI: 10.1016/J.Medmal.2006.05.018 |
0.396 |
|
2007 |
Ader F, Le Berre R, Lancel S, Faure K, Viget NB, Nowak E, Nevière R, Guery BP. Inhaled nitric oxide increases endothelial permeability in Pseudomonas aeruginosa pneumonia. Intensive Care Medicine. 33: 503-10. PMID 17219196 DOI: 10.1007/S00134-006-0497-7 |
0.785 |
|
2007 |
Buyck J, Faure K, Marechal X, Guery B, Matran R. 063 Is intracellular calcium concentration (Cai) in lung epithelial cells a signal for Pseudomonas aeruginosa type III secretion system (TTSS) activation ? Revue Des Maladies Respiratoires. 24: 1222. DOI: 10.1016/S0761-8425(07)74354-1 |
0.548 |
|
2006 |
Le Berre R, Faure K, Nguyen S, Pierre M, Ader F, Guery B. [Quorum sensing: a new clinical target for Pseudomonas aeruginosa?]. MéDecine Et Maladies Infectieuses. 36: 349-57. PMID 16631332 DOI: 10.1016/J.Medmal.2006.01.008 |
0.453 |
|
2006 |
Faure K, Leberre R, Guery B. [Pseudomonas aeruginosa and Surfactant-associated Proteins A and D]. Medecine Et Maladies Infectieuses. 36: 63-71. PMID 16406431 DOI: 10.1016/J.Medmal.2005.08.011 |
0.593 |
|
2006 |
Van Grunderbeeck N, Faure K, Husson M, Beermann C, Gottrand F, Guery B. 072 Augmentation de la Clairance Liquidienne Distale et potentialisation de la stimulation adrénergique par les acides gras n-3. Mise en évidence chez la souris Revue Des Maladies Respiratoires. 23: 550. DOI: 10.1016/S0761-8425(06)71900-3 |
0.458 |
|
2005 |
Boussekey N, Faure K, Guery B. Is combination the only issue? American Journal of Respiratory and Critical Care Medicine. 172: 1473-4; author reply. PMID 16301304 DOI: 10.1164/Ajrccm.172.11.1473 |
0.485 |
|
2005 |
Ader F, Le Berre R, Faure K, Gosset P, Epaulard O, Toussaint B, Polack B, Nowak E, Viget NB, Kipnis E, Guery BP. Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system. Infection and Immunity. 73: 4263-71. PMID 15972518 DOI: 10.1128/Iai.73.7.4263-4271.2005 |
0.489 |
|
2005 |
Boyer S, Faure K, Ader F, Husson MO, Kipnis E, Prangere T, Leroy X, Guery BP. Chronic pneumonia with Pseudomonas aeruginosa and impaired alveolar fluid clearance. Respiratory Research. 6: 17. PMID 15707485 DOI: 10.1186/1465-9921-6-17 |
0.641 |
|
2004 |
Guery B, d'Escrivan T, Georges H, Legout L, Leroy O, Viget N, Faure K. [Viral pneumonia in immunocompetent patients]. Reanimation : Journal De La Societe De Reanimation De Langue Francaise. 13: 226-237. PMID 32288722 DOI: 10.1016/J.Reaurg.2004.02.009 |
0.605 |
|
2004 |
Faure K, Sawa T, Ajayi T, Fujimoto J, Moriyama K, Shime N, Wiener-Kronish JP. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Respiratory Research. 5: 1. PMID 15040820 DOI: 10.1186/1465-9921-5-1 |
0.487 |
|
2004 |
Le Berre R, Faure K, Fauvel H, Viget NB, Ader F, Prangère T, Thomas AM, Leroy X, Pittet JF, Marchetti P, Guery BP. Apoptosis inhibition in P. aeruginosa-induced lung injury influences lung fluid balance. Intensive Care Medicine. 30: 1204-11. PMID 14991100 DOI: 10.1007/S00134-004-2165-0 |
0.79 |
|
2004 |
d'Escrivan T, Faure K, Boussekey N, Soubrier S, Guery B. B-14 Facteurs de risque de bactéries multi-résistantes chez les patients admis en réanimation pour une bactériémie nosocomiale MéDecine Et Maladies Infectieuses. 34: S142. DOI: 10.1016/S0399-077X(04)90144-8 |
0.51 |
|
2004 |
Le Berre R, Ader F, Faure K, Robriquet L, Epaulard O, Gosset P, Toussaint B, Guery B. CL6-03 Le système de sécrétion de type III: Un facteur de virulence important dans la pneumonie à Pseudomonas aeruginosa (Pa) MéDecine Et Maladies Infectieuses. 34: S83. DOI: 10.1016/S0399-077X(04)90062-5 |
0.699 |
|
2003 |
Faure K, Fujimoto J, Shimabukuro DW, Ajayi T, Shime N, Moriyama K, Spack EG, Wiener-Kronish JP, Sawa T. Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model. Journal of Immune Based Therapies and Vaccines. 1: 2. PMID 12943554 DOI: 10.1186/1476-8518-1-2 |
0.426 |
|
2001 |
Shime N, Sawa T, Fujimoto J, Faure K, Allmond LR, Karaca T, Swanson BL, Spack EG, Wiener-Kronish JP. Therapeutic administration of anti-PcrV F(ab′)2 in sepsis associated with Pseudomonas aeruginosa Journal of Immunology. 167: 5880-5886. PMID 11698464 DOI: 10.4049/Jimmunol.167.10.5880 |
0.415 |
|
Show low-probability matches. |